The need to quickly administer naloxone to counter opioid overdoses has spurred innovation in drug delivery for years, with intramuscular, subcutaneous and nasal doses all used, but the approaches all ...
The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...